We are live on ! Find out more
PRAX icon

Praxis Precision Medicines
PRAX

78 hedge funds and large institutions have $135M invested in Praxis Precision Medicines in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 19 increasing their positions, 25 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

212% more capital invested

Capital invested by funds: $43.1M → $135M (+$91.5M)

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

1.1% less ownership

Funds ownership: 6.77% → 5.68% (-1.1%)

9% less funds holding

Funds holding: 86 → 78 (-8)

24% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 25

27% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 30

Holders
78
Holders Change
-8
Holders Change %
-9.3%
% of All Funds
1.22%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
22
Increased
19
Reduced
25
Closed
30
Calls
$51K
Puts
–
Net Calls
+$51K
Net Calls Change
+$238K

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$10.7M
2
CAM
Cormorant Asset Management
Massachusetts
+$9.7M
3
SFM
Sphera Funds Management
Israel
+$8.95M
4
Verition Fund Management
Verition Fund Management
Connecticut
+$7.68M
5
PHS
PFM Health Sciences
California
+$6.85M

Top Sellers

1
APM
Avidity Partners Management
Texas
-$3.46M
2
BlackRock
BlackRock
New York
-$2.33M
3
GPP
Great Point Partners
Connecticut
-$1.64M
4
State Street
State Street
Massachusetts
-$774K
5
Goldman Sachs
Goldman Sachs
New York
-$620K
Name Holding Trade Value Shares
Change 		Change in
Stake
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$12.1M +$10.7M +700,000 +21,002%
Verition Fund Management
2
Verition Fund Management
Connecticut
$12.1M +$7.68M +501,700 +254%
CAM
3
Cormorant Asset Management
Massachusetts
$10.9M +$9.7M +633,333 New
PHS
4
PFM Health Sciences
California
$10.2M +$6.85M +447,678 +309%
SFM
5
Sphera Funds Management
Israel
$10.1M +$8.95M +584,289 New
Adage Capital Partners
6
Adage Capital Partners
Massachusetts
$9.12M +$6.13M +400,558 +313%
VA
7
VR Adviser
New York
$6.1M +$5.41M +353,627 New
KCM
8
Kingdon Capital Management
New York
$5.98M +$510K +33,334 +11%
VCIM
9
Velan Capital Investment Management
Georgia
$5.96M – – –
TLP
10
Tri Locum Partners
New York
$5.62M +$2.45M +159,751 +96%
Bank of America
11
Bank of America
North Carolina
$5.12M +$435K +28,427 +11%
ACP
12
Acuta Capital Partners
California
$4.89M +$4.34M +283,333 New
SCM
13
Silverarc Capital Management
Massachusetts
$4M +$3.55M +231,744 New
ABG
14
Ally Bridge Group
New York
$3.68M +$3.27M +213,333 New
Vanguard Group
15
Vanguard Group
Pennsylvania
$2.72M +$229K +14,978 +10%
SCM
16
Soleus Capital Management
Connecticut
$2.42M +$2.14M +140,000 New
BBA
17
Baker Bros. Advisors
New York
$2.16M – – –
Acadian Asset Management
18
Acadian Asset Management
Massachusetts
$1.77M +$150K +9,787 +11%
CIBC Asset Management
19
CIBC Asset Management
Ontario, Canada
$1.76M +$251K +16,401 +19%
VVA
20
Vida Ventures Advisors
Massachusetts
$1.69M – – –
ACM
21
Altium Capital Management
New York
$1.64M +$1.45M +95,000 New
MS
22
Maven Securities
Jersey
$1.55M +$1.38M +90,096 New
Jacobs Levy Equity Management
23
Jacobs Levy Equity Management
New Jersey
$1.5M +$1.33M +87,168 New
Millennium Management
24
Millennium Management
New York
$1.43M +$1.09M +71,462 +610%
Blackstone Inc
25
Blackstone Inc
New York
$1.21M – – –
1
2 3 4 5

PRAX Hedge Fund Activity: Q2 2023 in Review

78 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Praxis Precision Medicines (PRAX) for Q2 2023, worth a combined $135M — up 212% from $43.1M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of PRAX and 22 opened new positions — a net loss of 8 holders — while 25 trimmed existing stakes and 19 added.

The largest buyer was Point72 Asset Management, adding an estimated $10.7M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $3.46M sold.

  • 78 institutional investors held Praxis Precision Medicines (PRAX) as of Q2 2023, down from 86 in Q1 2023.
  • Funds reported $135M of Praxis Precision Medicines stock for Q2 2023, up 212% quarter-over-quarter.
  • 22 funds opened new Praxis Precision Medicines positions in Q2 2023 and 30 closed out, a net change of -8 holders.
  • The largest Praxis Precision Medicines buyer in Q2 2023 was Point72 Asset Management, an estimated $10.7M added.
  • The largest Praxis Precision Medicines seller in Q2 2023 was Avidity Partners Management, an estimated $3.46M sold.

Based on aggregated 13F filings for Q2 2023.